Global Personalized Precision Medicine Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Personalized Precision Medicine market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
Personalized precision medicine is an important development direction in the medical field. It is expected to provide patients with more effective and safer treatment options and improve medical quality and patient satisfaction.
This report is a detailed and comprehensive analysis for global Personalized Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Personalized Precision Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Personalized Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Personalized Precision Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca, Sanofi, Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Personalized Precision Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Precision Medicine, with revenue, gross margin, and global market share of Personalized Precision Medicine from 2020 to 2025.
Chapter 3, the Personalized Precision Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Personalized Precision Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Precision Medicine.
Chapter 13, to describe Personalized Precision Medicine research findings and conclusion.
Personalized precision medicine is an important development direction in the medical field. It is expected to provide patients with more effective and safer treatment options and improve medical quality and patient satisfaction.
This report is a detailed and comprehensive analysis for global Personalized Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Personalized Precision Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Personalized Precision Medicine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Personalized Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Personalized Precision Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca, Sanofi, Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Personalized Precision Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Gene Therapy
- Personalized Medication
- Health Management
- Others
- Tumors and Cancer
- Cardiovascular Diseases
- Genetic Disease
- Autoimmune Disease
- Others
- Agilent Technologies
- Biogen
- Johnson & Johnson
- Boai NKY Pharmaceuticals Ltd.
- Novartis
- Pfizer
- Roche
- AstraZeneca
- Sanofi
- Amgen
- Takeda Pharmaceutical
- Merck
- Eli Lilly
- IQVIA
- AbbVie
- Parexel
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Precision Medicine, with revenue, gross margin, and global market share of Personalized Precision Medicine from 2020 to 2025.
Chapter 3, the Personalized Precision Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Personalized Precision Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Precision Medicine.
Chapter 13, to describe Personalized Precision Medicine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Precision Medicine by Type
1.3.1 Overview: Global Personalized Precision Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Personalized Precision Medicine Consumption Value Market Share by Type in 2024
1.3.3 Gene Therapy
1.3.4 Personalized Medication
1.3.5 Health Management
1.3.6 Others
1.4 Global Personalized Precision Medicine Market by Application
1.4.1 Overview: Global Personalized Precision Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tumors and Cancer
1.4.3 Cardiovascular Diseases
1.4.4 Genetic Disease
1.4.5 Autoimmune Disease
1.4.6 Others
1.5 Global Personalized Precision Medicine Market Size & Forecast
1.6 Global Personalized Precision Medicine Market Size and Forecast by Region
1.6.1 Global Personalized Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Personalized Precision Medicine Market Size by Region, (2020-2031)
1.6.3 North America Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.4 Europe Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.6 South America Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Personalized Precision Medicine Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Personalized Precision Medicine Product and Solutions
2.1.4 Agilent Technologies Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Personalized Precision Medicine Product and Solutions
2.2.4 Biogen Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Biogen Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Personalized Precision Medicine Product and Solutions
2.3.4 Johnson & Johnson Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Boai NKY Pharmaceuticals Ltd.
2.4.1 Boai NKY Pharmaceuticals Ltd. Details
2.4.2 Boai NKY Pharmaceuticals Ltd. Major Business
2.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product and Solutions
2.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Personalized Precision Medicine Product and Solutions
2.5.4 Novartis Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Personalized Precision Medicine Product and Solutions
2.6.4 Pfizer Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Personalized Precision Medicine Product and Solutions
2.7.4 Roche Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Roche Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Personalized Precision Medicine Product and Solutions
2.8.4 AstraZeneca Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Personalized Precision Medicine Product and Solutions
2.9.4 Sanofi Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Personalized Precision Medicine Product and Solutions
2.10.4 Amgen Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Amgen Recent Developments and Future Plans
2.11 Takeda Pharmaceutical
2.11.1 Takeda Pharmaceutical Details
2.11.2 Takeda Pharmaceutical Major Business
2.11.3 Takeda Pharmaceutical Personalized Precision Medicine Product and Solutions
2.11.4 Takeda Pharmaceutical Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Personalized Precision Medicine Product and Solutions
2.12.4 Merck Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Merck Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Personalized Precision Medicine Product and Solutions
2.13.4 Eli Lilly Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 IQVIA
2.14.1 IQVIA Details
2.14.2 IQVIA Major Business
2.14.3 IQVIA Personalized Precision Medicine Product and Solutions
2.14.4 IQVIA Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 IQVIA Recent Developments and Future Plans
2.15 AbbVie
2.15.1 AbbVie Details
2.15.2 AbbVie Major Business
2.15.3 AbbVie Personalized Precision Medicine Product and Solutions
2.15.4 AbbVie Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 AbbVie Recent Developments and Future Plans
2.16 Parexel
2.16.1 Parexel Details
2.16.2 Parexel Major Business
2.16.3 Parexel Personalized Precision Medicine Product and Solutions
2.16.4 Parexel Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Parexel Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Precision Medicine Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Personalized Precision Medicine by Company Revenue
3.2.2 Top 3 Personalized Precision Medicine Players Market Share in 2024
3.2.3 Top 6 Personalized Precision Medicine Players Market Share in 2024
3.3 Personalized Precision Medicine Market: Overall Company Footprint Analysis
3.3.1 Personalized Precision Medicine Market: Region Footprint
3.3.2 Personalized Precision Medicine Market: Company Product Type Footprint
3.3.3 Personalized Precision Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Precision Medicine Consumption Value and Market Share by Type (2020-2025)
4.2 Global Personalized Precision Medicine Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Precision Medicine Consumption Value Market Share by Application (2020-2025)
5.2 Global Personalized Precision Medicine Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Personalized Precision Medicine Consumption Value by Type (2020-2031)
6.2 North America Personalized Precision Medicine Market Size by Application (2020-2031)
6.3 North America Personalized Precision Medicine Market Size by Country
6.3.1 North America Personalized Precision Medicine Consumption Value by Country (2020-2031)
6.3.2 United States Personalized Precision Medicine Market Size and Forecast (2020-2031)
6.3.3 Canada Personalized Precision Medicine Market Size and Forecast (2020-2031)
6.3.4 Mexico Personalized Precision Medicine Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Personalized Precision Medicine Consumption Value by Type (2020-2031)
7.2 Europe Personalized Precision Medicine Consumption Value by Application (2020-2031)
7.3 Europe Personalized Precision Medicine Market Size by Country
7.3.1 Europe Personalized Precision Medicine Consumption Value by Country (2020-2031)
7.3.2 Germany Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.3 France Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.5 Russia Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.6 Italy Personalized Precision Medicine Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Personalized Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2020-2031)
8.3.2 China Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.3 Japan Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.4 South Korea Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.5 India Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.7 Australia Personalized Precision Medicine Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Personalized Precision Medicine Consumption Value by Type (2020-2031)
9.2 South America Personalized Precision Medicine Consumption Value by Application (2020-2031)
9.3 South America Personalized Precision Medicine Market Size by Country
9.3.1 South America Personalized Precision Medicine Consumption Value by Country (2020-2031)
9.3.2 Brazil Personalized Precision Medicine Market Size and Forecast (2020-2031)
9.3.3 Argentina Personalized Precision Medicine Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Personalized Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2020-2031)
10.3.2 Turkey Personalized Precision Medicine Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Personalized Precision Medicine Market Size and Forecast (2020-2031)
10.3.4 UAE Personalized Precision Medicine Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Personalized Precision Medicine Market Drivers
11.2 Personalized Precision Medicine Market Restraints
11.3 Personalized Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Personalized Precision Medicine Industry Chain
12.2 Personalized Precision Medicine Upstream Analysis
12.3 Personalized Precision Medicine Midstream Analysis
12.4 Personalized Precision Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Precision Medicine by Type
1.3.1 Overview: Global Personalized Precision Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Personalized Precision Medicine Consumption Value Market Share by Type in 2024
1.3.3 Gene Therapy
1.3.4 Personalized Medication
1.3.5 Health Management
1.3.6 Others
1.4 Global Personalized Precision Medicine Market by Application
1.4.1 Overview: Global Personalized Precision Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tumors and Cancer
1.4.3 Cardiovascular Diseases
1.4.4 Genetic Disease
1.4.5 Autoimmune Disease
1.4.6 Others
1.5 Global Personalized Precision Medicine Market Size & Forecast
1.6 Global Personalized Precision Medicine Market Size and Forecast by Region
1.6.1 Global Personalized Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Personalized Precision Medicine Market Size by Region, (2020-2031)
1.6.3 North America Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.4 Europe Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.6 South America Personalized Precision Medicine Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Personalized Precision Medicine Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Personalized Precision Medicine Product and Solutions
2.1.4 Agilent Technologies Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Personalized Precision Medicine Product and Solutions
2.2.4 Biogen Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Biogen Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Personalized Precision Medicine Product and Solutions
2.3.4 Johnson & Johnson Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Boai NKY Pharmaceuticals Ltd.
2.4.1 Boai NKY Pharmaceuticals Ltd. Details
2.4.2 Boai NKY Pharmaceuticals Ltd. Major Business
2.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product and Solutions
2.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Boai NKY Pharmaceuticals Ltd. Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Personalized Precision Medicine Product and Solutions
2.5.4 Novartis Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Personalized Precision Medicine Product and Solutions
2.6.4 Pfizer Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Personalized Precision Medicine Product and Solutions
2.7.4 Roche Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Roche Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Personalized Precision Medicine Product and Solutions
2.8.4 AstraZeneca Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Personalized Precision Medicine Product and Solutions
2.9.4 Sanofi Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Personalized Precision Medicine Product and Solutions
2.10.4 Amgen Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Amgen Recent Developments and Future Plans
2.11 Takeda Pharmaceutical
2.11.1 Takeda Pharmaceutical Details
2.11.2 Takeda Pharmaceutical Major Business
2.11.3 Takeda Pharmaceutical Personalized Precision Medicine Product and Solutions
2.11.4 Takeda Pharmaceutical Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Personalized Precision Medicine Product and Solutions
2.12.4 Merck Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Merck Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Personalized Precision Medicine Product and Solutions
2.13.4 Eli Lilly Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 IQVIA
2.14.1 IQVIA Details
2.14.2 IQVIA Major Business
2.14.3 IQVIA Personalized Precision Medicine Product and Solutions
2.14.4 IQVIA Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 IQVIA Recent Developments and Future Plans
2.15 AbbVie
2.15.1 AbbVie Details
2.15.2 AbbVie Major Business
2.15.3 AbbVie Personalized Precision Medicine Product and Solutions
2.15.4 AbbVie Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 AbbVie Recent Developments and Future Plans
2.16 Parexel
2.16.1 Parexel Details
2.16.2 Parexel Major Business
2.16.3 Parexel Personalized Precision Medicine Product and Solutions
2.16.4 Parexel Personalized Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Parexel Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Precision Medicine Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Personalized Precision Medicine by Company Revenue
3.2.2 Top 3 Personalized Precision Medicine Players Market Share in 2024
3.2.3 Top 6 Personalized Precision Medicine Players Market Share in 2024
3.3 Personalized Precision Medicine Market: Overall Company Footprint Analysis
3.3.1 Personalized Precision Medicine Market: Region Footprint
3.3.2 Personalized Precision Medicine Market: Company Product Type Footprint
3.3.3 Personalized Precision Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Precision Medicine Consumption Value and Market Share by Type (2020-2025)
4.2 Global Personalized Precision Medicine Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Precision Medicine Consumption Value Market Share by Application (2020-2025)
5.2 Global Personalized Precision Medicine Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Personalized Precision Medicine Consumption Value by Type (2020-2031)
6.2 North America Personalized Precision Medicine Market Size by Application (2020-2031)
6.3 North America Personalized Precision Medicine Market Size by Country
6.3.1 North America Personalized Precision Medicine Consumption Value by Country (2020-2031)
6.3.2 United States Personalized Precision Medicine Market Size and Forecast (2020-2031)
6.3.3 Canada Personalized Precision Medicine Market Size and Forecast (2020-2031)
6.3.4 Mexico Personalized Precision Medicine Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Personalized Precision Medicine Consumption Value by Type (2020-2031)
7.2 Europe Personalized Precision Medicine Consumption Value by Application (2020-2031)
7.3 Europe Personalized Precision Medicine Market Size by Country
7.3.1 Europe Personalized Precision Medicine Consumption Value by Country (2020-2031)
7.3.2 Germany Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.3 France Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.5 Russia Personalized Precision Medicine Market Size and Forecast (2020-2031)
7.3.6 Italy Personalized Precision Medicine Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Personalized Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2020-2031)
8.3.2 China Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.3 Japan Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.4 South Korea Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.5 India Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Personalized Precision Medicine Market Size and Forecast (2020-2031)
8.3.7 Australia Personalized Precision Medicine Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Personalized Precision Medicine Consumption Value by Type (2020-2031)
9.2 South America Personalized Precision Medicine Consumption Value by Application (2020-2031)
9.3 South America Personalized Precision Medicine Market Size by Country
9.3.1 South America Personalized Precision Medicine Consumption Value by Country (2020-2031)
9.3.2 Brazil Personalized Precision Medicine Market Size and Forecast (2020-2031)
9.3.3 Argentina Personalized Precision Medicine Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Personalized Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2020-2031)
10.3.2 Turkey Personalized Precision Medicine Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Personalized Precision Medicine Market Size and Forecast (2020-2031)
10.3.4 UAE Personalized Precision Medicine Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Personalized Precision Medicine Market Drivers
11.2 Personalized Precision Medicine Market Restraints
11.3 Personalized Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Personalized Precision Medicine Industry Chain
12.2 Personalized Precision Medicine Upstream Analysis
12.3 Personalized Precision Medicine Midstream Analysis
12.4 Personalized Precision Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Personalized Precision Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Personalized Precision Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Personalized Precision Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Personalized Precision Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Personalized Precision Medicine Product and Solutions
Table 8. Agilent Technologies Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Biogen Company Information, Head Office, and Major Competitors
Table 11. Biogen Major Business
Table 12. Biogen Personalized Precision Medicine Product and Solutions
Table 13. Biogen Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Biogen Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Personalized Precision Medicine Product and Solutions
Table 18. Johnson & Johnson Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Boai NKY Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 20. Boai NKY Pharmaceuticals Ltd. Major Business
Table 21. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product and Solutions
Table 22. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Boai NKY Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 24. Novartis Company Information, Head Office, and Major Competitors
Table 25. Novartis Major Business
Table 26. Novartis Personalized Precision Medicine Product and Solutions
Table 27. Novartis Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novartis Recent Developments and Future Plans
Table 29. Pfizer Company Information, Head Office, and Major Competitors
Table 30. Pfizer Major Business
Table 31. Pfizer Personalized Precision Medicine Product and Solutions
Table 32. Pfizer Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Pfizer Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Personalized Precision Medicine Product and Solutions
Table 37. Roche Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Roche Recent Developments and Future Plans
Table 39. AstraZeneca Company Information, Head Office, and Major Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Personalized Precision Medicine Product and Solutions
Table 42. AstraZeneca Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. AstraZeneca Recent Developments and Future Plans
Table 44. Sanofi Company Information, Head Office, and Major Competitors
Table 45. Sanofi Major Business
Table 46. Sanofi Personalized Precision Medicine Product and Solutions
Table 47. Sanofi Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Sanofi Recent Developments and Future Plans
Table 49. Amgen Company Information, Head Office, and Major Competitors
Table 50. Amgen Major Business
Table 51. Amgen Personalized Precision Medicine Product and Solutions
Table 52. Amgen Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen Recent Developments and Future Plans
Table 54. Takeda Pharmaceutical Company Information, Head Office, and Major Competitors
Table 55. Takeda Pharmaceutical Major Business
Table 56. Takeda Pharmaceutical Personalized Precision Medicine Product and Solutions
Table 57. Takeda Pharmaceutical Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Takeda Pharmaceutical Recent Developments and Future Plans
Table 59. Merck Company Information, Head Office, and Major Competitors
Table 60. Merck Major Business
Table 61. Merck Personalized Precision Medicine Product and Solutions
Table 62. Merck Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Recent Developments and Future Plans
Table 64. Eli Lilly Company Information, Head Office, and Major Competitors
Table 65. Eli Lilly Major Business
Table 66. Eli Lilly Personalized Precision Medicine Product and Solutions
Table 67. Eli Lilly Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Eli Lilly Recent Developments and Future Plans
Table 69. IQVIA Company Information, Head Office, and Major Competitors
Table 70. IQVIA Major Business
Table 71. IQVIA Personalized Precision Medicine Product and Solutions
Table 72. IQVIA Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. IQVIA Recent Developments and Future Plans
Table 74. AbbVie Company Information, Head Office, and Major Competitors
Table 75. AbbVie Major Business
Table 76. AbbVie Personalized Precision Medicine Product and Solutions
Table 77. AbbVie Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. AbbVie Recent Developments and Future Plans
Table 79. Parexel Company Information, Head Office, and Major Competitors
Table 80. Parexel Major Business
Table 81. Parexel Personalized Precision Medicine Product and Solutions
Table 82. Parexel Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Parexel Recent Developments and Future Plans
Table 84. Global Personalized Precision Medicine Revenue (USD Million) by Players (2020-2025)
Table 85. Global Personalized Precision Medicine Revenue Share by Players (2020-2025)
Table 86. Breakdown of Personalized Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in Personalized Precision Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key Personalized Precision Medicine Players
Table 89. Personalized Precision Medicine Market: Company Product Type Footprint
Table 90. Personalized Precision Medicine Market: Company Product Application Footprint
Table 91. Personalized Precision Medicine New Market Entrants and Barriers to Market Entry
Table 92. Personalized Precision Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global Personalized Precision Medicine Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global Personalized Precision Medicine Consumption Value Share by Type (2020-2025)
Table 95. Global Personalized Precision Medicine Consumption Value Forecast by Type (2026-2031)
Table 96. Global Personalized Precision Medicine Consumption Value by Application (2020-2025)
Table 97. Global Personalized Precision Medicine Consumption Value Forecast by Application (2026-2031)
Table 98. North America Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of Personalized Precision Medicine Upstream (Raw Materials)
Table 129. Global Personalized Precision Medicine Typical Customers
Table 1. Global Personalized Precision Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Personalized Precision Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Personalized Precision Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Personalized Precision Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Personalized Precision Medicine Product and Solutions
Table 8. Agilent Technologies Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Biogen Company Information, Head Office, and Major Competitors
Table 11. Biogen Major Business
Table 12. Biogen Personalized Precision Medicine Product and Solutions
Table 13. Biogen Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Biogen Recent Developments and Future Plans
Table 15. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Personalized Precision Medicine Product and Solutions
Table 18. Johnson & Johnson Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Boai NKY Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 20. Boai NKY Pharmaceuticals Ltd. Major Business
Table 21. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product and Solutions
Table 22. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Boai NKY Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 24. Novartis Company Information, Head Office, and Major Competitors
Table 25. Novartis Major Business
Table 26. Novartis Personalized Precision Medicine Product and Solutions
Table 27. Novartis Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novartis Recent Developments and Future Plans
Table 29. Pfizer Company Information, Head Office, and Major Competitors
Table 30. Pfizer Major Business
Table 31. Pfizer Personalized Precision Medicine Product and Solutions
Table 32. Pfizer Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Pfizer Recent Developments and Future Plans
Table 34. Roche Company Information, Head Office, and Major Competitors
Table 35. Roche Major Business
Table 36. Roche Personalized Precision Medicine Product and Solutions
Table 37. Roche Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Roche Recent Developments and Future Plans
Table 39. AstraZeneca Company Information, Head Office, and Major Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Personalized Precision Medicine Product and Solutions
Table 42. AstraZeneca Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. AstraZeneca Recent Developments and Future Plans
Table 44. Sanofi Company Information, Head Office, and Major Competitors
Table 45. Sanofi Major Business
Table 46. Sanofi Personalized Precision Medicine Product and Solutions
Table 47. Sanofi Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Sanofi Recent Developments and Future Plans
Table 49. Amgen Company Information, Head Office, and Major Competitors
Table 50. Amgen Major Business
Table 51. Amgen Personalized Precision Medicine Product and Solutions
Table 52. Amgen Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen Recent Developments and Future Plans
Table 54. Takeda Pharmaceutical Company Information, Head Office, and Major Competitors
Table 55. Takeda Pharmaceutical Major Business
Table 56. Takeda Pharmaceutical Personalized Precision Medicine Product and Solutions
Table 57. Takeda Pharmaceutical Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Takeda Pharmaceutical Recent Developments and Future Plans
Table 59. Merck Company Information, Head Office, and Major Competitors
Table 60. Merck Major Business
Table 61. Merck Personalized Precision Medicine Product and Solutions
Table 62. Merck Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Recent Developments and Future Plans
Table 64. Eli Lilly Company Information, Head Office, and Major Competitors
Table 65. Eli Lilly Major Business
Table 66. Eli Lilly Personalized Precision Medicine Product and Solutions
Table 67. Eli Lilly Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Eli Lilly Recent Developments and Future Plans
Table 69. IQVIA Company Information, Head Office, and Major Competitors
Table 70. IQVIA Major Business
Table 71. IQVIA Personalized Precision Medicine Product and Solutions
Table 72. IQVIA Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. IQVIA Recent Developments and Future Plans
Table 74. AbbVie Company Information, Head Office, and Major Competitors
Table 75. AbbVie Major Business
Table 76. AbbVie Personalized Precision Medicine Product and Solutions
Table 77. AbbVie Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. AbbVie Recent Developments and Future Plans
Table 79. Parexel Company Information, Head Office, and Major Competitors
Table 80. Parexel Major Business
Table 81. Parexel Personalized Precision Medicine Product and Solutions
Table 82. Parexel Personalized Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Parexel Recent Developments and Future Plans
Table 84. Global Personalized Precision Medicine Revenue (USD Million) by Players (2020-2025)
Table 85. Global Personalized Precision Medicine Revenue Share by Players (2020-2025)
Table 86. Breakdown of Personalized Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in Personalized Precision Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key Personalized Precision Medicine Players
Table 89. Personalized Precision Medicine Market: Company Product Type Footprint
Table 90. Personalized Precision Medicine Market: Company Product Application Footprint
Table 91. Personalized Precision Medicine New Market Entrants and Barriers to Market Entry
Table 92. Personalized Precision Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global Personalized Precision Medicine Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global Personalized Precision Medicine Consumption Value Share by Type (2020-2025)
Table 95. Global Personalized Precision Medicine Consumption Value Forecast by Type (2026-2031)
Table 96. Global Personalized Precision Medicine Consumption Value by Application (2020-2025)
Table 97. Global Personalized Precision Medicine Consumption Value Forecast by Application (2026-2031)
Table 98. North America Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific Personalized Precision Medicine Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa Personalized Precision Medicine Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa Personalized Precision Medicine Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa Personalized Precision Medicine Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of Personalized Precision Medicine Upstream (Raw Materials)
Table 129. Global Personalized Precision Medicine Typical Customers
LIST OF FIGURES
Figure 1. Personalized Precision Medicine Picture
Figure 2. Global Personalized Precision Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Personalized Precision Medicine Consumption Value Market Share by Type in 2024
Figure 4. Gene Therapy
Figure 5. Personalized Medication
Figure 6. Health Management
Figure 7. Others
Figure 8. Global Personalized Precision Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Personalized Precision Medicine Consumption Value Market Share by Application in 2024
Figure 10. Tumors and Cancer Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Genetic Disease Picture
Figure 13. Autoimmune Disease Picture
Figure 14. Others Picture
Figure 15. Global Personalized Precision Medicine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Personalized Precision Medicine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Market Personalized Precision Medicine Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 18. Global Personalized Precision Medicine Consumption Value Market Share by Region (2020-2031)
Figure 19. Global Personalized Precision Medicine Consumption Value Market Share by Region in 2024
Figure 20. North America Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 21. Europe Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 22. Asia-Pacific Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 23. South America Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 24. Middle East & Africa Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Personalized Precision Medicine Revenue Share by Players in 2024
Figure 27. Personalized Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 28. Market Share of Personalized Precision Medicine by Player Revenue in 2024
Figure 29. Top 3 Personalized Precision Medicine Players Market Share in 2024
Figure 30. Top 6 Personalized Precision Medicine Players Market Share in 2024
Figure 31. Global Personalized Precision Medicine Consumption Value Share by Type (2020-2025)
Figure 32. Global Personalized Precision Medicine Market Share Forecast by Type (2026-2031)
Figure 33. Global Personalized Precision Medicine Consumption Value Share by Application (2020-2025)
Figure 34. Global Personalized Precision Medicine Market Share Forecast by Application (2026-2031)
Figure 35. North America Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 36. North America Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 37. North America Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 42. Europe Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 43. Europe Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 45. France Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 59. South America Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 60. South America Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 61. Brazil Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 62. Argentina Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 63. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 64. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 65. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 66. Turkey Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 67. Saudi Arabia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 68. UAE Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 69. Personalized Precision Medicine Market Drivers
Figure 70. Personalized Precision Medicine Market Restraints
Figure 71. Personalized Precision Medicine Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Personalized Precision Medicine Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Personalized Precision Medicine Picture
Figure 2. Global Personalized Precision Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Personalized Precision Medicine Consumption Value Market Share by Type in 2024
Figure 4. Gene Therapy
Figure 5. Personalized Medication
Figure 6. Health Management
Figure 7. Others
Figure 8. Global Personalized Precision Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Personalized Precision Medicine Consumption Value Market Share by Application in 2024
Figure 10. Tumors and Cancer Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Genetic Disease Picture
Figure 13. Autoimmune Disease Picture
Figure 14. Others Picture
Figure 15. Global Personalized Precision Medicine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Personalized Precision Medicine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Market Personalized Precision Medicine Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 18. Global Personalized Precision Medicine Consumption Value Market Share by Region (2020-2031)
Figure 19. Global Personalized Precision Medicine Consumption Value Market Share by Region in 2024
Figure 20. North America Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 21. Europe Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 22. Asia-Pacific Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 23. South America Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 24. Middle East & Africa Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Personalized Precision Medicine Revenue Share by Players in 2024
Figure 27. Personalized Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 28. Market Share of Personalized Precision Medicine by Player Revenue in 2024
Figure 29. Top 3 Personalized Precision Medicine Players Market Share in 2024
Figure 30. Top 6 Personalized Precision Medicine Players Market Share in 2024
Figure 31. Global Personalized Precision Medicine Consumption Value Share by Type (2020-2025)
Figure 32. Global Personalized Precision Medicine Market Share Forecast by Type (2026-2031)
Figure 33. Global Personalized Precision Medicine Consumption Value Share by Application (2020-2025)
Figure 34. Global Personalized Precision Medicine Market Share Forecast by Application (2026-2031)
Figure 35. North America Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 36. North America Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 37. North America Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 42. Europe Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 43. Europe Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 45. France Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Personalized Precision Medicine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 59. South America Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 60. South America Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 61. Brazil Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 62. Argentina Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 63. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Type (2020-2031)
Figure 64. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Application (2020-2031)
Figure 65. Middle East & Africa Personalized Precision Medicine Consumption Value Market Share by Country (2020-2031)
Figure 66. Turkey Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 67. Saudi Arabia Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 68. UAE Personalized Precision Medicine Consumption Value (2020-2031) & (USD Million)
Figure 69. Personalized Precision Medicine Market Drivers
Figure 70. Personalized Precision Medicine Market Restraints
Figure 71. Personalized Precision Medicine Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Personalized Precision Medicine Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
